Novo Nordisk | Beban Penjualan Dan Administrasi



Selling And Administration Expenses Perubahan Tanggal
ANI Pharmaceuticals USD 81.77M 5.24M 2025-06
Aurora Cannabis CAD 38.18M 2.05M 2024-12
Bausch Health Companies USD 894M 27M 2025-06
Bristol-Myers Squibb USD 1.71B 129M 2025-06
Canopy Growth CAD 40.62M 308K 2024-12
Corcept Therapeutics USD 103.85M 13.19M 2025-06
Drreddys Laboratories INR 21.59B 436M 2024-12
Eli Lilly USD 2.75B 390.8M 2025-06
GlaxoSmithKline GBP 2.14B 80M 2025-06
Merck USD 2.63B 104M 2025-06
Novartis USD 3.44B 384M 2025-06
Novo Nordisk 18.85B 2.74B 2025-06
Novo Nordisk DKK 16.11B 480M 2025-03
Pacira USD 77.19M 9.58M 2025-06
Perrigo USD 273.1M 8.1M 2025-06
Prestige Brands USD 28.46M 35.6M 2025-06
Sanofi EUR 2.63B 408M 2025-06
Supernus Pharmaceuticals USD 62.22M 27.72M 2025-06
Zoetis USD 617M 54M 2025-06


Novo Nordisk Beban Penjualan Dan Administrasi - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Aug 2025.